LATASHA TURNER: Open Payments
NPI 1174000137 · EASLEY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$906 in 45 payments from 14 companies in 2025. Trend: 2023 $857 · 2024 $779 · 2025 $906
Food & beverage: $906
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $248 |
| AstraZeneca Pharmaceuticals LP | 11 | $229 |
| Lilly USA, LLC | 8 | $120 |
| Astellas Pharma US Inc | 3 | $92 |
| Exact Sciences Corporation | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| SANOFI-AVENTIS U.S. LLC | 1 | $27 |
| Eisai Inc. | 1 | $22 |
| Edwards Lifesciences Corporation | 1 | $21 |
| PFIZER INC. | 1 | $19 |
Products named: Ozempic, AIRSUPRA, FARXIGA, Veozah, MOUNJARO, JARDIANCE, BREZTRI, Rybelsus.
Industry payments across SC — which companies pay providers there.
